Arvind Sahu

956 total citations
46 papers, 678 citations indexed

About

Arvind Sahu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Arvind Sahu has authored 46 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 11 papers in Surgery. Recurrent topics in Arvind Sahu's work include Gastric Cancer Management and Outcomes (9 papers), Gastrointestinal Tumor Research and Treatment (7 papers) and Lung Cancer Research Studies (5 papers). Arvind Sahu is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Gastrointestinal Tumor Research and Treatment (7 papers) and Lung Cancer Research Studies (5 papers). Arvind Sahu collaborates with scholars based in India, Australia and China. Arvind Sahu's co-authors include Kumar Prabhash, Amit Joshi, Saral Desai, Vanita Noronha, Anant Ramaswamy, Suman Saha, S. Bahadur, Vikas Ostwal, Shobha Lata Sinha and Tikendra Nath Verma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Arvind Sahu

43 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arvind Sahu India 14 307 245 176 119 66 46 678
Hyunjin Kim South Korea 16 226 0.7× 227 0.9× 101 0.6× 152 1.3× 24 0.4× 69 687
Akiko Uchida Japan 15 268 0.9× 232 0.9× 138 0.8× 212 1.8× 41 0.6× 54 756
Kenji Yoshida Japan 19 182 0.6× 152 0.6× 140 0.8× 233 2.0× 31 0.5× 57 838
Xuekui Liu China 18 159 0.5× 156 0.6× 274 1.6× 250 2.1× 108 1.6× 105 1.1k
Nektaria Makrilia Greece 15 287 0.9× 325 1.3× 126 0.7× 280 2.4× 30 0.5× 23 1.0k
Shinji Nagata Japan 21 451 1.5× 276 1.1× 267 1.5× 372 3.1× 132 2.0× 80 1.2k
Chia‐Chi Lin Taiwan 15 340 1.1× 356 1.5× 108 0.6× 297 2.5× 38 0.6× 44 835
Viviana Murgia Italy 13 212 0.7× 206 0.8× 59 0.3× 156 1.3× 36 0.5× 32 739
Qiuxia Dong China 8 198 0.6× 330 1.3× 74 0.4× 131 1.1× 19 0.3× 18 537
Neeraj Rastogi India 16 120 0.4× 114 0.5× 165 0.9× 207 1.7× 82 1.2× 41 578

Countries citing papers authored by Arvind Sahu

Since Specialization
Citations

This map shows the geographic impact of Arvind Sahu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Sahu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Sahu more than expected).

Fields of papers citing papers by Arvind Sahu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Sahu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Sahu. The network helps show where Arvind Sahu may publish in the future.

Co-authorship network of co-authors of Arvind Sahu

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind Sahu. A scholar is included among the top collaborators of Arvind Sahu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind Sahu. Arvind Sahu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahu, Arvind, et al.. (2025). Exploring AI tools and multi-omics for precision medicine in lung cancer therapy. Cytokine & Growth Factor Reviews. 84. 135–157. 2 indexed citations
2.
Sahu, Arvind, et al.. (2025). Advancement in hepatocellular carcinoma research: Biomarkers, therapeutics approaches and impact of artificial intelligence. Computers in Biology and Medicine. 198(Pt A). 111120–111120.
3.
Sahu, Arvind, et al.. (2022). The treatment of resectable gastric cancer: a literature review of an evolving landscape. Journal of Gastrointestinal Oncology. 13(2). 871–884. 4 indexed citations
4.
5.
Sahu, Arvind, et al.. (2021). Immune Checkpoint Inhibitor in First-Line Treatment of Metastatic Renal Cell Carcinoma: A Review of Current Evidence and Future Directions. Frontiers in Oncology. 11. 707214–707214. 40 indexed citations
6.
Bahadur, S., et al.. (2019). Current promising treatment strategy for glioblastoma multiform: A review. Oncology Reviews. 13(2). 417–417. 74 indexed citations
7.
Chaudhari, Vikram, Vikas Ostwal, Shraddha Patkar, et al.. (2018). Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications. HPB. 20(9). 841–847. 53 indexed citations
8.
Ostwal, Vikas, Arvind Sahu, Saurabh Zanwar, et al.. (2018). Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer. The Indian Journal of Medical Research. 148(3). 284–290. 5 indexed citations
9.
Ramaswamy, Anant, et al.. (2018). Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer. Indian Journal of Cancer. 55(1). 88–88. 4 indexed citations
10.
Verma, Tikendra Nath, Arvind Sahu, & Shobha Lata Sinha. (2017). Study of Particle Dispersion on One Bed Hospital using Computational Fluid Dynamics. Materials Today Proceedings. 4(9). 10074–10079. 31 indexed citations
11.
Ramaswamy, Anant, Amit Joshi, Vanita Noronha, et al.. (2016). Patterns of Care and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma—Results From a Tertiary Cancer Center in India. Clinical Genitourinary Cancer. 15(3). e345–e355. 9 indexed citations
12.
Ramaswamy, Anant, Vikas Ostwal, Nikhil Pande, et al.. (2016). Second-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective Option. Journal of Gastrointestinal Cancer. 47(3). 305–312. 16 indexed citations
13.
Ramaswamy, Anant, Vikas Ostwal, Omshree Shetty, et al.. (2016). Neoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?. Journal of Gastrointestinal Cancer. 47(4). 381–388. 5 indexed citations
14.
Zanwar, Saurabh, Vikas Ostwal, Arvind Sahu, et al.. (2016). Rectal GIST—Outcomes and viewpoint from a tertiary cancer center. Indian Journal of Gastroenterology. 35(6). 445–449. 8 indexed citations
15.
Sahu, Arvind, Anant Ramaswamy, & Vikas Ostwal. (2016). Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience. Journal of Gastrointestinal Oncology. 7(3). 380–386. 14 indexed citations
16.
Sahu, Arvind, Rahul Sharma, Bhanushree Gupta, et al.. (2016). Oxime-mediatedin vitroreactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase. Toxicology Mechanisms and Methods. 26(5). 319–326. 6 indexed citations
17.
Noronha, Vanita, Anant Ramaswamy, Vijay Patil, et al.. (2016). ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country. PLoS ONE. 11(9). e0160752–e0160752. 26 indexed citations
18.
Ostwal, Vikas, Reena Engineer, Anant Ramaswamy, et al.. (2016). Surgical outcomes of post chemoradiotherapy unresectable locally advanced rectal cancers improve with interim chemotherapy, is FOLFIRINOX better than CAPOX?. Journal of Gastrointestinal Oncology. 7(6). 958–967. 10 indexed citations
19.
Sahu, Arvind, Preetesh Jain, Shailesh V. Shrikhande, et al.. (2015). Sunitinib in patients with imatinib-resistant gastrointestinal stromal tumor: A single center experiencep-190 chronic myelogenous leukemia presenting as extramedullary blast crisis. Indian Journal of Cancer. 52(3). 320–320. 4 indexed citations
20.
Prabhash, Kumar, Vanita Noronha, Amit Joshi, Saral Desai, & Arvind Sahu. (2013). Crizotinib: A comprehensive review. SHILAP Revista de lepidopterología. 2(2). 91–91. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyunjin Kim Breakdown of academic impact, for papers by Akiko Uchida Breakdown of academic impact, for papers by Kenji Yoshida Breakdown of academic impact, for papers by Xuekui Liu Breakdown of academic impact, for papers by Nektaria Makrilia Breakdown of academic impact, for papers by Shinji Nagata Breakdown of academic impact, for papers by Chia‐Chi Lin Breakdown of academic impact, for papers by Viviana Murgia Breakdown of academic impact, for papers by Qiuxia Dong Breakdown of academic impact, for papers by Neeraj Rastogi
Rankless by CCL
2026